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Abstract
Coreceptor use of HIV can evolve during infection. We previously examined coreceptor use of related SIVsm inoculum viruses and
sequential reisolates from cynomolgus macaques. These viruses exhibited broad coreceptor specificities and, generally, CCR5 use remained
efficient and stable, while alternative coreceptor use decreased longitudinally. Here we demonstrate that individual envelopes (Envs) from
inoculum and reisolate viruses fuse via a range of coreceptors, including CCR5, CCR8, CXCR6, GPR15, GPR1, and APJ. On the whole,
coreceptor use of Envs from sequential reisolates recapitulated that of reisolate viruses, thus CCR5 use remained stable while alternative
coreceptor use tended to decrease over time. Rhesus CCR5, GPR15, and CXCR6 supported fusion to a similar extent as their human
counterparts. Additionally, a number of Envs mediated CD4-independent fusion via CCR5 and GPR15. Envs from different inoculum
viruses exhibited distinct dependencies on CD4 for fusion via CCR5, ranging from strictly CD4-dependent to efficiently CD4-independent.
Early reisolates from macaques infected with CD4-independent inoculums maintained or evolved Envs with a broad range of CD4-
independence. CD4-independence became less variable/efficient in late reisolates from macaques that developed neutralizing antibodies.
Infection with a CD4-dependent virus resulted in evolution of CD4-independent Envs in late reisolates. While CD4 independence can
potentially broaden tropism in vivo, CD4-independent viruses are particularly sensitive to neutralizing antibodies. Therefore, interplay
between receptor tropism and neutralization may shape viral evolution and SIV pathogenesis.
© 2003 Elsevier Inc. All rights reserved.
Introduction
Simian immunodeficiency virus (SIV) infection of ma-
caques is often used as a model for human immunodefi-
ciency virus (HIV) infection of humans. In experimental
SIV infection the time and route of infection as well as the
inoculum virus and the infectious dose are controlled. An-
other advantage of the macaque system is that events oc-
curring immediately after infection can be followed. In
humans, early sequelea of HIV infection can rarely be
studied since the onset of symptoms, if any at all, can occur
several weeks after infection.
HIV or SIV infection begins with an acute phase char-
acterized by a high level of virus replication resulting in a
peak viral load in the infected individual. Subsequently,
there is a characteristic decline in viral load to a steady-state
level, called the viral set point, which is predictive of the
severity of infection and disease course (Ho, 1997; Musey et
al., 1997; Rinaldo et al., 1995). Decline in viral load is a
consequence of activation of the host’s immune response,
which controls viral replication to varying degrees during
the asymptomatic phase of infection (Koup et al., 1994;
Schmitz et al., 1999). With increasing destruction of the
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immune system, the balance between host control and virus
replication is lost leading to increased plasma viral load,
accelerated loss of CD4 cells, and clinical symptoms of
immunodeficiency.
To enter target cells, HIV and SIV usually require an
interaction with both CD4 and a secondary coreceptor mol-
ecule on the cell surface (Alkhatib et al., 1996; Choe et al.,
1996; Deng et al., 1996; Doranz et al., 1996; Dragic et al.,
1996; Feng et al., 1996). Viruses isolated during the asymp-
tomatic phase of HIV-1 infection most often use the che-
mokine receptor molecule CCR5 (R5 viruses; Berger et al.,
1998). During progressive disease approximately 50% of
HIV-1-infected individuals acquire viruses that utilize a
related chemokine receptor, CXCR4, either in place of (X4
viruses) or in addition to CCR5 (R5X4 viruses) (Bjo¨rndal et
al., 1997; Scarlatti et al., 1997). SIV isolates from infected
monkeys (SIVsm and SIVmac of sooty mangabey origin,
isolated from sooty mangabey or macaque, respectively)
also use CCR5 as coreceptor (Chen et al., 1997; Edinger et
al., 1997a; Marcon et al., 1997). In addition, they often use
CXCR6 (formerly STRL33/Bonzo) and/or GPR15/BOB
(Deng et al., 1997; Edinger et al., 1998; Farzan et al., 1997).
However, unlike HIV-1, progressive SIV disease is not
associated with a change in viral tropism to CXCR4 use. In
general, CXCR4 use is rare among SIV strains, and at least
in one case was the result of extensive in vitro passage in
human peripheral blood lymphocytes (Owen et al., 2000;
Schols and De Clercq, 1998; Vo¨dro¨s et al., 2001). In addi-
tion, reisolated viruses from macaques infected with a
CXCR4 using isolate lost the ability to use CXCR4 (Vo¨dro¨s
et al., 2001), suggesting control of CXCR4-using viruses in
the monkey host or selection for reduced coreceptor speci-
ficity.
While primary HIV-1 isolates are almost exclusively
CD4-dependent, CD4-independent use of coreceptors by
HIV-2 (Endres et al., 1996; Liu et al., 2000; Reeves et al.,
1997, 1999) and SIV strains (Edinger et al., 1997b, 1999;
Liu et al., 2000; Reeves et al., 1997; Schenten et al., 1999)
has been reported. In addition, several HIV-1 strains have
been selected for CD4-independent use of either CCR5 or
CXCR4 (Dumonceaux et al., 1998; Hoffman et al., 1999;
Kolchinsky et al., 1999; LaBranche et al., 1999). Since
T-cell line-adapted CD4-independent HIV-1 strains and
SIV variant envelopes are highly sensitive to inhibition by
neutralizing antibodies (Edwards et al., 2001; Kolchinsky et
al., 2001; Puffer et al., 2002), the humoral immune response
may control the emergence of CD4-independent variants in
vivo.
We previously reported that a subset of coreceptor mol-
ecules could mediate infection of variant SIVsm strains and
sequential reisolates obtained from infected cynomologus
macaques (Edinger et al., 1997b, 1999; Liu et al., 2000;
Reeves et al., 1997; Schenten et al., 1999). We observed
stable use of CCR5 by inoculum and reisolated viruses and
declining utilization of CXCR6, GPR15, and CXCR4 over
time. To extend these studies, we cloned envelope genes
from inoculum viruses and reisolates from SIVsm-infected
cynomolgus macaques that exhibited fast or slow disease
progression and in which the neutralizing antibody response
was known. We examined Env clones for their ability to
mediate fusion on an extended panel of coreceptor mole-
cules, enabling us to determine if broad coreceptor tropism
was a feature of individual Env clones or resulted from a
virus swarm of mixed coreceptor specificities. CD4-inde-
pendent use of coreceptors was also addressed by analyzing
the fusion capacity of envelope clones in the presence or
absence of CD4.
Results
Cloning functional SIV envelopes from inoculum viruses
and sequential reisolates
We have previously studied the coreceptor use of related
SIVsm inoculum viruses (SIVsmA, SIVsmB, and SIVsmC)
with different passage histories (detailed in the materials
and methods section and summarized below) and sequential
viral reisolates from cynomolgus macaques infected with
these viruses (Vo¨dro¨s et al., 2001). Inoculum viruses orig-
inated from the SIVsm isolate SMM-3, obtained from a
naturally infected Sooty mangabey (Vo¨dro¨s et al., 2001).
SIVsmA originated from SMM-3 that was passaged twice
on HUT-78 cells, followed by two passages on human (h)
PBMCs. SIVsmB was derived by further passage of
SIVsmA on hPBMCs for 3 months. SIVsmC was isolated
on hPBMCs by coculture with PBMCs from a symptomatic
cynomolgus macaque that had been inoculated with
SIVsmA. Inoculum and reisolated viruses exhibited broad
coreceptor specificities (Vo¨dro¨s et al., 2001), detailed in the
material and methods section and Table 1. In general, CCR5
use of inoculum and reisolated viruses remained efficient
and stable, while the efficiency of alternative coreceptor use
decreased over time.
Env genes were cloned from inoculum and reisolate
viruses to determine whether the coreceptor tropism of
these viruses was conferred by individual Env genes or
Env genes of different coreceptor specificities. Viral en-
velope genes, amplified in two to four independent PCR
reactions from genomic DNA isolated from virus-in-
fected human PBMC (described in detail in the materials
and methods section) were cloned into the pCI-PRE ex-
pression vector. On average, four or five clones from
each independent PCR reaction were analyzed; 88% of
clones (168 of 191) screened by restriction digestion
contained Env gene inserts of expected size. Clones con-
taining appropriate sized inserts were tested for function
in a cell-cell fusion assay. Since all viral isolates were
previously shown to use CCR5 efficiently and stably as a
coreceptor for infection of GHOST(3) cells (Vo¨dro¨s et
al., 2001), the ability of Env clones to fuse with CD4/
CCR5 cells was determined (Fig. 1, and data not
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Fig. 1. Functional screening of viral Env clones. Fusion between Env-expressing effector cells (infected with a vaccinia virus encoding T7 polymerase) and
receptor-expressing target cells (cotransfected with a T7-luciferase reporter plasmid). Fusion of effector and target cells results in luciferase expression. RLU,
relative light units indicating luciferase activity; pcDNA3.1, control plasmid. Results represent fusion of Env clones from inoculum and reisolate viruses from
one animal (H9).
Table 1
Characteristics of SIVsm inoculated monkeys: coreceptor use of sequential reisolates and neutralizing antibody production
Monkey SIVsm
inoculuma
Death with
immonudeficiency
(days PI)
Virus isolation
(days)b
Corecepor use of reisolatesc Serum neutralizing activityd
Early Middle Late Against
isolate
At indicated
day
Reciprocal
titer
MF8 A 541 12-137-541 CCR5, CXCR6,
GPR15
CCR5, CXCR6,
GPR15
CCR5 [GPR15] inoculum d137 160
12d d137 640
MF10 A 541 12-226-541 CCR5, CXCR6,
GPR15
CCR5, CXCR6,
GPR15
CCR5, CXCR6,
GPR15
inoculum d226 40
12d d226 320
H9 B 174 12-174 CCR5, CCR3,
CXCR4,
CXCR6,
GPR15
CCR5, CXCR6,
GPR15
inoculum d174 320
12d d174 320
H56 B 898 12-217-365-538-898 CCR5, GPR15 inoculum d217, d365,
d538
320
12d d217 320
12d d365 40
12d d538 80
217d d365, d538 20
365d d538 40
538d d538 80
H27 C 145 12-145 CCR5, GPR15
[CXCR6]
CCR5, GPR15 none
H28 C 607 12-125-365-607 CCR5, GPR15
[CXCR6]
CCR5, GPR15
[CXCR6]
CCR5 [GPR15] inoculum d125 80
12d d125, d365 40
125d d365 320
a Inoculum A and C were used undiluted, H9 received 105 monkey infectious dose-50 (MID50), while H56 was inoculated with 101–102 MID50 of
inoculum B.
b Isolates underlined were tested for coreceptor use; envelopes were cloned from isolates in bold face.
c Summarized from Vo¨dro¨s et al. (2001); CCR3, CCR5, CXCR4, CXCR6 and GPR15/BOB coreceptor utilization determined on CD4 GHOST(3) cell
lines. Weak use of coreceptor is indicated by parenthesis. Early, middle, late refers to reisolation date tested (see b).
d Summarized from data based on Zhang et al. (1993).
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shown); 86% of Env clones tested (101 of 118) were
fusion competent. Selected functional clones were then
subjected to further detailed analysis, as described below.
Coreceptor use of SIVsm envelope clones from inoculum
and reisolated viruses
The coreceptor use of selected envelopes cloned from
SIVsm inoculum viruses as well as from early (12 days
postinfection) and late (time of overt immunodeficiency)
reisolates from five cynomolgus macaques was exam-
ined. QT6 quail cells transfected with envelope clones
were assayed for their ability to fuse with cells express-
ing CD4 and various coreceptors. Since all SIV isolates
were shown to use CCR5 efficiently in the presence of
CD4, the fusion capacity of Env clones via other core-
ceptors was expressed as a percentage of fusion via
CCR5 (Fig. 2). All Env clones were multicoreceptor
tropic with efficient fusion detected via a number of
coreceptors, with one exception: clone 16/1d (an individ-
ual clone from a day 145 reisolate of monkey H27) used
only CXCR6 in addition to CCR5, while almost all other
Envs mediated fusion via CXCR6, GPR15, and fre-
quently GPR1 in addition to CCR5. In general, the core-
ceptor use of clonally derived envelopes was thus similar
to the pattern of infection observed with the correspond-
ing isolates on GHOST(3) cells (Table 1), in that both
clones and biological isolates could use CCR5, CXCR6,
and GPR15. Using the cell-cell fusion assay, we observed
that Env clones derived from both SIVsmB-infected an-
Fig. 2. Coreceptor use of envelope clones obtained from inoculum, early and late viral reisolates from SIVsm-infected cynomolgus macaques. The coreceptor
use of two to four Env clones from each animal at each time point were analyzed. % Fusion, fusion between effector cells expressing indicated Envs and
target cells expressing CD4 and indicated coreceptor, expressed as a percentage of fusion via target cells expressing CD4 and CCR5. Time points of virus
reisolations are indicated. Coreceptor use of clones from macaque MF8 and H9 represent an average of three assays, coreceptor use of clones from macaque
H27 represent an average of two assays, and the coreceptor use of clones from macaque H28 and H56 represent the average of replicates from individual
experiments. The y-axes of panels A–D are plotted at equivalent scales (100% fusion value circled). The y-axes of panels E and F are plotted to a maximum
value of 14% fusion (circled).
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imals and one SIVsmC-infected monkey showed a de-
cline in use of certain alternative receptors compared to
the inoculum virus. This is consistent with our earlier
study in which we noted a decline in use of these recep-
tors (especially CXCR6) when virus isolates were tested
in infectivity assays on GHOST(3) cells (Vo¨dro¨s et al.,
2001). In addition, Env clones from SIVsmB inoculum
virus used CXCR4 inefficiently, consistent with the abil-
ity of SIVsmB inoculum and day 12 reisolated viruses
(H9:12) to infect GHOST(3) cells expressing CXCR4
(Vo¨dro¨s et al., 2001).
The ability of Env clones to mediate fusion with cells
expressing CD4 and a range of other viral coreceptors
(not tested in infection assays) was also determined (Fig.
2, and data not shown). Clones from SIVsmB inoculum
and reisolates mediated fusion via APJ to a level com-
parable to GPR15. Again, compared to inoculum and
early reisolate clones, the efficiency of APJ use declined
over time. Other inoculum and reisolate clones generally
exhibited a lesser degree of fusion via APJ. CCR8 sup-
ported a low level of fusion for SIVsmB inoculum and
day 12 reisolate clones. Later SIVsmB reisolate clones
exhibited no or minimal CCR8 use, as did SIVsmA and
SIVsmC inoculum and reisolate clones. CCR1, CCR2,
CXCR1, and CX3CR1 did not support fusion of any
clones examined (data not shown).
In summary, the coreceptor use of Env clones deter-
mined in cell-cell fusion assays largely recapitulated results
obtained previously with virus isolates. Thus, individual
Env clones were found to be multicoreceptor tropic. The
SIVsmB inoculum, which was extensively passaged in
hPBMCs, and early/rapid progressor SIVsmB reisolate
clones generally exhibited a broader coreceptor tropism
and more efficient fusion profile on GPR1-, APJ-,
CCR8-, and CXCR4-expressing cells than clones from
the other inoculum and reisolated viruses, suggesting that
passage of the SIVsmB inoculum on human PBMCs
resulted in expanded coreceptor tropism. SIVsmB was
the only inoculum able to use CXCR4 as a coreceptor.
Thus, prolonged passage of this isolate on hPBMCs,
known to express a high level of CXCR4 (Bleul et al.,
1997), might have selected for CXCR4 using variants.
SIVsmA inoculum (grown in the HUT-78 T-cell line,
followed by two passages in hPBMCs) and reisolates
exhibited similar coreceptor use profiles to SIVsmC in-
oculum (derived from an infected cynomolgus macaque
with only two passages on hPBMCs), indicating that
isolation on HUT-78 cells did not skew coreceptor use
away from that maintained in vivo.
Utilization of rhesus coreceptors
In general, specific human coreceptors and their ma-
caque equivalents are both able to support infection of
SIV. However, some important differences have
emerged. For example, rhesus macaque CXCR6 appears
to be a less efficient coreceptor for SIVmac strains than
human CXCR6 (Pohlmann et al., 2000). Therefore, Env
clones from animals MF8 and H9 and the corresponding
inoculum viruses (SIVsm A and B, respectively) were
tested for fusion capacity via the rhesus counterparts of
CCR5, CXCR6, and GPR15 in the presence of human
CD4. Results obtained with rhesus CCR5 or GPR15
paralleled those obtained with the human chemokine re-
ceptors (Fig. 3A and B), in that all clones that fused with
human CCR5 or GPR15 coreceptors were also able to
fuse with rhesus CCR5 or GPR15.
Variable CD4 independence of inoculum virus envelopes
clones
Some SIV and HIV-2 isolates can mediate CD4-inde-
pendent infection via CCR5 or CXCR4 (Edinger et al.,
1997b, 1999; Endres et al., 1996; Liu et al., 2000; Reeves et
al., 1997, 1999; Schenten et al., 1999). We therefore exam-
ined whether Env clones from SIVsmA, B, or C inoculum
viruses could mediate CD4-independent infection. Relative
CD4-independence was determined by assaying Env-medi-
ated fusion of cells expressing CCR5 with or without CD4.
Env clones from each of the inoculum viruses differed in
their CD4-independent use of CCR5 (Fig. 4). Env clones
from SIVsmA, which was isolated on HUT-78 cells from a
naturally infected sooty mangabey and passaged twice on
human PBMCs, fused with CD4-negative CCR5-expressing
cells with 16–27% efficiency compared to CD4/CCR5
cells. In contrast, prolonged in vitro passage of SIVsmA in
human PBMC yielded the SIVsmB inoculum virus from
which strictly CD4-dependent clones were obtained.
SIVsmC inoculum, derived following in vivo passage of
SIVsmA in a cynomolgus macaque, yielded envelopes that
widely varied in CD4-independent CCR5 fusion capacity
ranging 23–75% efficiency compared to CD4/CCR5 cells.
The differences in CD4-dependence/independence of the
inoculum viruses made it particularly interesting to deter-
mine whether further evolution of CD4 independence oc-
curred in vivo.
Evolution of CD4 independence in vivo
Envelope clones from reisolated virus obtained from two
SIVsmA (MF8 and MF10), two SIVsmB (H9 and H56), and
two SIVsmC (H27 and H28) infected cynomolgus ma-
caques were examined for their ability to mediate CD4-
independent fusion via CCR5. The majority of envelope
clones tested were able to fuse to some extent with CCR5-
expressing cells in the absence of CD4 (Fig. 4B). Individual
envelope clones from day 12 reisolates from SIVsmC in-
fected animals (H27 and H28) remained divergent in their
ability to mediate CD4-independent fusion (Fig. 5D), with
some clones exhibiting little CD4 independence while oth-
ers were able to utilize CCR5 with similar efficiency
whether CD4 was present or absent. Env clones from day 12
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reisolates from SIVsmA infected animals exhibited a mark-
edly expanded range of CD4-independence (MF8, 3–84%,
MF10, 0–54%, compared to SIVsmA inoculum envelope
clones, 16–27%; Fig. 4A). Interestingly, in three of the
SIVsmA- and SIVsmC-infected animals (MF8, MF10, and
H28), variation in CD4-independent CCR5 use decreased
over time (Fig. 4A and B). In contrast, clones from the late
isolate of H27 showed a comparably broad range of CD4
independence as did the early clones derived from this
animal. This animal did not develop a detectable neutraliz-
ing antibody response and died of immunodeficiency within
5 months of SIV infection, whereas MF8, MF10, and H28
developed neutralizing antibodies against both inoculum
virus and early reisolates and survived infection for 18 to 20
months (Table 1).
A different pattern of evolution was seen following in-
oculation with the CD4-dependent SIVsmB virus, with CD4
independence evolving gradually over time (Fig. 4C).
Clones from the early reisolate (day 12) of H9 were simi-
larly CD4 dependent in CCR5 use as the inoculum virus.
Some degree of CD4-independence evolved in this animal
over the course of infection. Four of five clones tested from
the late reisolate of H9 used CCR5 alone with 16–31%
efficiency, while the fifth clone tested was highly efficient in
CD4-independent CCR5 use (153%). An early reisolate was
not available from monkey H56; however, clones from 365
and 898 days reisolates showed large variation in CD4-inde-
pendent CCR5 use, variation being the most pronounced at the
later time point (14–158% CD4 independence).
Env clones from MF8, H9, and inoculum viruses
(SIVsmA and SIVsmB, respectively) were also tested for
the ability to mediate CD4-independent fusion via a range
of coreceptors. GPR15 supported CD4-independent fusion
of clones derived from both animals (Fig. 3C and D) though
the efficiency was on whole reduced compared to CCR5.
Envs from MF8 evolved CD4-independent use of GPR15
and enhanced CD4-independence via CCR5 during the first
2 weeks of infection. The efficiency of CD4-independent
fusion via both CCR5 and GPR15 decreased by day 541
post infection. In contrast, monkey H9 was inoculated with
a virus that was highly dependent on CD4 for CCR5 use and
minimally CD4-independent via GPR15. This pattern was
maintained in clones from the 12-day reisolate, while late
isolates exhibited a marked enhancement of CD4-indepen-
dent CCR5 fusion and a more modest increase in CD4-
independent fusion via GPR15.
MF8 and H9 clones were also examined for CD4-inde-
pendent use of rhesus CCR5 (98.6% and 100% amino acid
homology to human and cynomolgus macaque receptors,
respectively) and rhesus GPR15 (97.2% and 99.2% amino
acid homology to human and cynomolgus macaque recep-
tors, respectively; Margulies et al., 2001). The pattern of
CD4-independent fusion was similar with human and rhesus
CCR5 and GPR15 receptors (Fig. 3C and D). Interestingly,
rhesus CCR5 supported CD4-independent fusion more ef-
ficiently in monkey MF8 than human CCR5. This has been
reported previously for SIVmac envelope clones (Edinger et
al., 1999; Martin et al., 1997). CD4-independent fusion with
GPR15, however, was slightly less efficient with the rhesus
receptor compared to the human receptor. In conclusion, the
Fig. 3. CD4-dependent and CD4-independent fusion via human and rhesus CCR5 and GPR15. (A and B) Fusion capacity of envelope clones from SIVsmA
(MF8) and SIVsmB (H9) inoculated macaques on CD4 rhesus (rh) and human CCR5- or GPR15-expressing cells, expressed as a percentage of fusion via
CD4- and CCR5-expressing cells. (C and D) CD4-independent fusion via human and rhesus CCR5 and GPR15, expressed as a percentage of fusion in the
presence of CD4. Error bars represent average value  SD for all clones tested.
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in vivo evolution of CD4-independent CCR5 use by SIVsm
viruses can vary depending on the properties of inoculum
viruses. Furthermore, fusion of SIV envelopes with CCR5
in the absence of CD4 suggests that evolution of CD4
independence may be important for pathogenesis in vivo,
either directly or indirectly.
Fig. 4. CD4-independence of inoculum and reisolate virus Env clones from SIVsmA- SIVsmB-, and SIVsmC-infected cynomolgus macaques. CD4-
independent fusion via human CCR5 of Env clones derived from animals infected with SIVsmA (A), SIVsmC (B), or SIVsmB (C). Fusion expressed as a
percentage of fusion via target cells expressing CD4 and CCR5. Values represent the average of replicates from one to five independent experiments.
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Discussion
Coreceptor use of envelope clones from inoculum vi-
ruses and sequential reisolates from SIVsm-infected cyno-
molgus macaques, with slow or fast disease progression and
known neutralizing antibody titers, was evaluated in a cell:
cell fusion assay and compared to the ability of correspond-
ing isolates to infect GHOST(3) cells expressing CCR3,
CCR5, CXCR4, CXCR6, or GPR15 receptors (Vo¨dro¨s et
al., 2001). The ability of Env clones to mediate fusion via an
extended range of coreceptors, including GPR1 and APJ,
known to mediate fusion and infection by several SIV
isolates and SIV envelope clones (summarized in Broder
and Jones-Trower, 1999), was also examined. Our results
show that all clones from inoculum viruses, day 12 resio-
lates, and late reisolates (obtained at the time of immuno-
deficiency) were able to fuse with varying efficiencies to
cells expressing a range of coreceptors that included CCR5,
CXCR6, GPR15, GPR1, APJ, and CCR8 in the presence of
CD4. The coreceptor use of Env clones reflected the core-
ceptor specificity of corresponding viral isolates, establish-
ing that these clonally derived envelopes are multicorecep-
tor tropic. Each envelope has the capacity to mediate fusion
via a range of coreceptors that potentially confers a wide
cell tropism to the viral isolates.
Some differences between isolates and clonal derivatives
were observed. Notably, all clones fused very efficiently
with CXCR6-expressing cells, whereas CXCR6-mediated
infection of late isolates varied greatly, and three late iso-
lates were not able to infect GHOST(3) cells expressing
CXCR6. There are several possible explanations for this
difference. First, fusion and infection are different phenom-
ena. It is possible that envelope clones mediate virus attach-
ment to CD4 and CXCR6 resulting in fusion of target and
effector cells, whereas they fail to mediate a postentry step
that might be important for efficient entry and replication in
target cells. This would be supported by our previous find-
ings demonstrating that some late isolates entered
GHOST(3) indicator cells expressing CXCR6 (viral Tat-
induced GFP expression was detected), but were not able to
establish productive infection (measured by viral p27 pro-
duction in culture supernatants) (Vo¨dro¨s et al., 2001). Sec-
ond, differences in receptor expression levels (Platt et al.,
1998) or receptor conformation (Baribaud and Doms, 2001;
Baribaud et al., 2001) between cells used for fusion and
infection may account for varied results. Third, it is also
possible that the clones are representative of a minority
virus population. However, we feel this is less likely since
isolates and clones otherwise exhibit a similar pattern of
coreceptor use and there were no major differences in fusion
capacity among the different clones derived from the same
isolate.
CXCR4 use also differed slightly between clones and
isolates. Two viruses [SIVsmB and the day 12 reisolate
from macaque H9 (H9:12)] used CXCR4 in the GHOST
cell assay. Fusion capacity of corresponding envelope
clones with the CXCR4 receptor was less pronounced than
infection by the isolates. However, infection of
GHOST(3).CXCR4 cells with SIVsmB and H9:12 was only
partly inhibited by AMD3100, a specific CXCR4 antago-
nist, and early isolates could infect the parental GHOST(3)
cells (engineered to express CD4 only but known to express
low level of endogenous CXCR4) in the presence of
AMD3100. Thus we hypothesized that another coreceptor
might be expressed on the GHOST(3) cells that can be used
by the majority of early isolates (Vo¨dro¨s et al., 2001). GPR1
is also expressed endogenously on GHOST cells (Soda et
al., 1999); however, a consistent pattern of GPR1 use by all
Env clones would indicate the presence of a further, as yet
unidentified, coreceptor.
Env clones from inoculum viruses with different passage
histories were found to exhibit divergent dependence on
CD4 for fusion via CCR5. Clones derived from SIVsmA
inoculum, isolated on HUT-78 cells from a naturally in-
fected sooty mangabey and passaged twice on hPBMCs,
exhibited a relatively narrow range of CD4-independence
(16–27%). Further extensive passage on hPBMCs resulted
in SIVsmB inoculum from which strictly CD4-dependent
clones were derived, suggesting that CD4-dependent vi-
ruses may be more fit under these conditions. In vivo pas-
sage of SIVsmA in a cynomolgus macaque, followed by
reisolation on hPBMCs, resulted in SIVsmC inoculum that
gave rise to Env clones exhibiting a broad range of CD4-
independence. The typically high level of virus replication
observed early after infection can result in a high level of
viral diversity. Virions with a phenotype different from the
inoculum virus can emerge and replicate. While Env clones
from the SIVsmA inoculum virus were relatively homoge-
neous in CD4-independent CCR5 use, 12 days after infec-
tion clonal derivatives of reisolates varied widely in their
capacity to fuse with CCR5-expressing cells in the absence
of CD4. The high rate of mutations accumulated during
virus replication along with depletion of CD4 T cells at the
sites of SIV replication early after infection (Kewenig et al.,
1999; Vajdy et al., 2001; Zhou et al., 1999) might select for
CD4-independent SIV variants. Variability in CD4-inde-
pendent CCR5 use decreased over time in three of four
SIVsmA- or SIVsmC-infected macaques resulting in an
equivalent or lower level of CD4-independent CCR5 use as
that seen with inoculum virus clones. These three animals
were able to mount neutralizing antibody responses to the
inoculum virus and the 12-day reisolate. In contrast, clones
from the fourth monkey showed large variation in CD4-
independent CCR5 use both early and late and this animal
did not mount a neutralizing antibody response. The hu-
moral immune response may thus play a role in controlling
CD4-independent virus variants during infection. This is in
line with findings of Schmitz et al. (2003) who showed that
virus specific antibodies contribute to the control of SIV
replication. Recently, Ryzhova et al. (2002) found that
CD4-independent envelopes could be isolated from rapid
progressor macaques. They found that amino acid changes
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at positions 383 and 385 of the SIV envelope distinguished
CD4-dependent and independent envelopes. We sequenced
three envelope clones from the 12-day isolate of monkey
MF8 that differed in CD4-independent use of CCR5 (84%,
30%, or 24%) and found no difference among the clones in
these positions. CD4-independent use of CCR5 seems to be
coincident with convergent envelope evolution in rapid pro-
gressor animals that also lack neutralizing antibodies
(Dehghani et al., 2003). We suggest that the lack of neu-
tralizing antibodies may contribute to rapid disease progres-
sion and to the evolution of CD4-independent coreceptor
use. It will be interesting to compare the neutralization
sensitivity of different Env clones obtained from this study.
CD4-independent use of coreceptors and neutralization sen-
sitivity of envelopes have been shown to be closely related
phenomena (Edwards et al., 2001; Kolchinsky et al., 2001;
Means et al., 2001; Puffer et al., 2002). In general, binding
of envelope to CD4 leads to conformational changes within
gp120 that allow binding to a coreceptor (Kwong et al.,
1998; Lapham et al., 1996; Trkola et al., 1996; Wu et al.,
1996). Envelopes that bind to coreceptors in a CD4-inde-
pendent manner are likely to have a “more open” confor-
mation, similar to CD4-triggered CD4-dependent envelopes
(Hoffman et al., 1999). Neutralizing antibodies can recog-
nize epitopes in gp120 that becomes exposed after CD4
binding (Javaherian et al., 1994). It is therefore likely that
viruses with neutralization-sensitive CD4-independent phe-
notype are selected against in vivo by the host immune
response, in particular by antibodies (Beaumont et al., 2001;
Choi et al., 1994; Ye et al., 2000).
Inoculation of SIVsmB into macaques resulted in a dif-
ferent pattern of CD4-independent CCR5 use. Clones from
SIVsmB inoculum were strictly CD4-dependent for fusion
via CCR5. Clones from the day 12 reisolate from H9 also
exhibited a high degree of CD4-dependence. In a few
months, however, the virus population became heteroge-
nous and clones appeared that used CCR5 very efficiently in
the absence of CD4. This animal was inoculated with a high
dose of SIVsm (105 MID) and died early of immunode-
ficiency. Even if there was a strong neutralizing antibody
response to the inoculum virus and the day 12 reisolates, the
virus recovered at 6 months post infection was resistant to
autologous neutralization (Zhang et al., 1993). H56 was
inoculated with 1000–10,000-fold less SIVsmB virus. The
first clones recovered at day 365 post infection exhibited a
broad range of CD4-independence. CD4-independence in-
creased over time with five of eight clones using CCR5
efficiently in the absence of CD4 at day 898. Neutralizing
antibody titers against late reisolates were low (Table 1;
Zhang et al., 1993).
Our results indicate that there is an initial expansion of
viral diversity early after infection that is subsequently con-
trolled either by the immune system or viral selection.
Evidence to support this hypothesis is threefold as follows:
(1) early but not late viral reisolates exhibit an expanded
receptor tropism for the parental GHOST(3) cells (Vo¨dro¨s
et al., 2001); (2) changes in the pattern of CD4-independent
CCR5 use of envelope clones derived from sequential iso-
lates; and (3) quality of neutralizing antibody response in-
dicated by increased neutralizing antibody titers against
isolates compared to titers against inoculum virus (Table 1).
On the whole these points indicate that early after infection
there is a rapid change in the virus population, resulting in
the emergence of new variants that are relatively CD4-
independent and neutralization sensitive, supporting previ-
ous studies (Edwards et al., 2001; Kolchinsky et al., 2001;
Means et al., 2001; Parren et al., 1999; Puffer et al., 2002).
It is likely that expanded tropism, replicative advantage, and
sensitivity to neutralization with autologous antibody,
alongside cellular immune responses, are selective forces
that contribute to establishment of a viral equilibrium during
the asymptomatic phase of infection, with increasing viral
replication gradually resulting in immunodeficiency and
less viral control. Selection of CD4-independent SIVsm
variants early after infection with SIVsmA may play a
significant role in promoting virus replication, though these
viruses appear to be controlled later after infection, perhaps
because CD4-independence has thus far been invariably
associated with enhanced sensitivity to neutralizing antibod-
ies. Evolution to CD4-independence/dependence in con-
junction with the humoral immune response likely shape the
course of SIV pathogenesis.
Materials and methods
Animals and viruses
The SIVsm isolate SMM-3 (kindly provided by P. Fultz
and H. McClure, Yerkes Regional Primate Research Center,
Atlanta, GA) originated from a naturally infected sooty
mangabey (Cercocebus atys) (Fultz et al., 1986). This virus
was isolated and passaged twice in the human T-cell line
HUT-78, followed by two passages in human peripheral
blood mononuclear cells (hPBMC) (Putkonen et al., 1989).
Virus derived from cell-free supernatant of hPBMC cul-
tures, harvested 8 days after infection, was the source of
inoculum A. Inoculum B was derived by further passage of
inoculum A on hPBMC for 3 months. Inoculum C was
derived from a cynomolgus macaque that had been infected
with inoculum A and developed diarrhea, weight loss, and
tachypnea 245 days post inoculation. Virus was reisolated
from macaque PBMCs by cocultivation with hPBMC and
the cell-free supernatant of this coculture was used as inoc-
ulum C.
All three inoculum viruses used CCR5, CXCR6, and
GPR15 as coreceptors for infection of CD4 GHOST(3)
indicator cell lines (Vo¨dro¨s et al., 2001). In addition,
SIVsmB was also able to use CXCR4 (Vo¨dro¨s et al., 2001).
Eight cynomolgus macaques were infected intravenously
with SIVsmA (4), SIVsmB (2), or SIVsmC (2) iso-
lates (Putkonen et al., 1989; Zhang et al., 1993) and the
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coreceptor use of reisolated viruses examined (Vo¨dro¨s et al.,
2001). Coreceptor use of day 12 reisolates was similar to
that of inoculum viruses (Vo¨dro¨s et al., 2001) (Table 1).
CCR5 use remained stable in later reisolates while the
capacity to use other coreceptors decreased over time (Vo¨-
dro¨s et al., 2001).
Sera from seven SIVsm-infected macaques exhibited
neutralizing activity (Zhang et al., 1993; Table 1). Sera
obtained at specific time points post infection could neu-
tralize previous but not current or subsequent isolates, with
the exception of macaque H27 that did not mount any
neutralizing antibody response. Sera obtained from animals
with the latest onset of immunodeficiency (H28 and H56)
appeared to have the broadest neutralizing activity, since
they could neutralize virus isolates derived from other
SIVsm-infected macaques (Zhang et al., 1993).
Amplification and cloning of SIV envelopes
Viral envelope genes were cloned from inoculum viruses
and reisolates obtained from six cynomolgus macaques in-
oculated with SIVsmA (2), SIVsmB (2), or SIVsmC
(2) as follows: Human PBMCs were infected with inoc-
ulum or reisolated viruses, 7 days post infection, cytopath-
icity was apparent and genomic DNA was isolated from
infected cells with a Qiagen blood and cell culture DNA kit;
250, 50, or 10 ng of genomic DNA was used as a template
for PCR amplification of envelopes using SIVsmFI (5
CTAATAACGCGTCTGCATCAGACAAGTAAGTATG
3) and SIVsmRI (5 CATCAGCGGCCGCATCTACAT-
CATCCATGTTTTGTT 3) oligonucleotides. Two to four
independently amplified PCR products were cut with MluI
and NotI restriction enzymes (restriction sites in oligonu-
cleotides) and envelope genes ligated into the MluI/
PspOMI-restricted pCI-PRE expression vector (kindly pro-
vided by Ted C. Pierson). Four or five clones were selected
from each ligated PCR product and screened by restriction
digestion to determine whether plasmids contained Env
gene inserts of the expected size. The functionality of Env
gene clones was determined in a cell-cell fusion assay, as
described below.
Cell-cell fusion assay
QT6 “effector” cells, transfected with Env expression
plasmids and infected with a vaccinia virus encoding T7
polymerase (vTF1.1) (Alexander et al., 1992), were added
to QT6 “target” cells cotransfected with a luciferase reporter
construct under the control of a T7 promotor (T7-luc), CD4,
and coreceptor or pcDNA3.1 (control) expression plasmids.
Cell:cell fusion, resulting from a functional interaction be-
tween Env-expressing effector cells and receptor-expressing
target cells, was detected by assaying for T7 polymerase-
driven luciferase expression. This assay has been described
in detail previously (Rucker et al., 1997).
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